M.M. Dillon & Co acted as a financial advisor to Cardax Inc (OTC CDXI ) in its registered public exchange offer for 27.5 million warrants into newly issued warrants and…

MM Dillon acted as an advisor to CareDx, Inc. (Nasdaq:CDNA) the completion of its previously announced acquisition of publically traded Allenex AB. The acquisition included a successful tender of 98.37%…

M.M. Dillon & Company (“Dillon”) acted as sole financial advisor to QuantaSol Ltd. In its sale to JDSU (NASDAQ: JDSU). JDSU is now Viavi Solutions. Terms of the transaction were…

MM Dillon advised Inovio in the spin-off of GENEOS Therapeutics, Inc., to develop and commercialize neo-antigen based personalized cancer therapies. While Inovio pursues the unique potential of its SynCon® immunotherapy…

MM Dillon advised the minority shareholders of Texas Spine & Joint Hospital (TSJH) which has partnered with Baylor Scott & White Health (BSWH) and United Surgical Partners International (USPI). MM…

Acquicor Technology Inc. (“Acquicor” or the “Company”) acquired Jazz Semiconductor, Inc. (“Jazz”) for $26 million. M.M. Dillon & Co. (“Dillon”) was engaged to act as financial advisor to Acquicor. The…

M.M. Dillon & Co. (“Dillon”) was engaged to act as financial advisor to JANA Partners (“JANA” or the “Acquiror”) in connection with a potential acquisition of CNET Networks, Inc. (“CNET”…

M.M.Dillon & Company (“Dillon”) acted as sole financial advisor to Redfern Intergrated Optics (RIO) in its sale to OptaSense, a subsidiary of QinetiQ Group plc. The transaction required Committee on…

CRT Capital Group LLC n/k/a M.M. Dillon & Co. served as financial advisor to Schultze Asset Management, LLC. in connection with the review of the $35 million private placement of…

M.M. Dillon & Co. (“Dillon”) acted as sole financial advisor to Carlyle Mexico Partners in its sale of Hispanic Teleservices Corporation (“HTC”) to Teleperformance. Dillon previously served as the sole…